---
annotations:
- id: PW:0000013
  parent: disease pathway
  type: Pathway Ontology
  value: disease pathway
- id: DOID:9452
  parent: genetic disease
  type: Disease Ontology
  value: fatty liver disease
- id: CL:0000182
  parent: native cell
  type: Cell Type Ontology
  value: hepatocyte
authors:
- JJvdHeijden
- AlexanderPico
- Marvin M2
- Jkearns445
- ChesdeWindt
- Eweitz
- Finterly
- MysticArchers
- Mkutmon
- Khanspers
citedin: ''
communities:
- AOP
- ONTOX
description: 'This liver steatosis AOP starts from the top with different molecular
  initiating events going down towards liver steatosis. The black nodes are Key Events
  and green nodes are molecular pathways.   Adverse outcome pathway liver steatosis;
  the accumulation of lipids in hepatocytes, caused either by over-nutrition, visceral
  obesity, metabolic syndrome, or environmental toxins. Liver steatosis can be divided
  into three main categories: alcoholic liver disease (ALD), non-alcoholic  liver
  disease (NAFLD), and toxicant-associated liver disease (TAFLD).[Review on liver
  steatosis](https://pubmed.ncbi.nlm.nih.gov/28210688/).'
last-edited: 2025-03-07
ndex: 1605d5b7-8b69-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4010
- /instance/WP4010
- /instance/WP4010_r137676
revision: r137676
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4010.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'This liver steatosis AOP starts from the top with different molecular
    initiating events going down towards liver steatosis. The black nodes are Key
    Events and green nodes are molecular pathways.   Adverse outcome pathway liver
    steatosis; the accumulation of lipids in hepatocytes, caused either by over-nutrition,
    visceral obesity, metabolic syndrome, or environmental toxins. Liver steatosis
    can be divided into three main categories: alcoholic liver disease (ALD), non-alcoholic  liver
    disease (NAFLD), and toxicant-associated liver disease (TAFLD).[Review on liver
    steatosis](https://pubmed.ncbi.nlm.nih.gov/28210688/).'
  keywords: []
  license: CC0
  name: Liver steatosis adverse outcome pathway
seo: CreativeWork
title: Liver steatosis adverse outcome pathway
wpid: WP4010
---